Suppr超能文献

用于恢复人类肠道微生物群失调的现代益生菌开发的最新进展

Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis.

作者信息

Kumar Roshan, Sood Utkarsh, Gupta Vipin, Singh Mona, Scaria Joy, Lal Rup

机构信息

PhiXGen Private Limited, Gurugram, Haryana 122001 India.

2Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD USA.

出版信息

Indian J Microbiol. 2020 Mar;60(1):12-25. doi: 10.1007/s12088-019-00808-y. Epub 2019 May 25.

Abstract

A healthy gut is predominantly occupied by bacteria which play a vital role in nutrition and health. Any change in normal gut homeostasis imposes gut dysbiosis. So far, efforts have been made to mitigate the gastrointestinal symptoms using modern day probiotics. The majority of the probiotics strains used currently belong to the genera , , and . Recent advancements in culturomics by implementing newer techniques coupled with the use of gnotobiotic animal models provide a subtle ground to develop novel host specific probiotics therapies. In this review article, the recent advances in the development of microbe-based therapies which can now be implemented to treat a wide spectrum of diseases have been discussed. However, these probiotics are not classified as drugs and there is a lack of stringent law enforcement to protect the end users against the pseudo-probiotic products. While modern probiotics hold strong promise for the future, more rigorous regulations are needed to develop genuine probiotic products and characterize novel probiotics using the latest research and technology. This article also highlights the possibility of reducing antibiotic usage by utilizing probiotics developed using the latest concepts of syn and ecobiotics.

摘要

健康的肠道主要由细菌占据,这些细菌在营养和健康方面发挥着至关重要的作用。正常肠道内环境稳定的任何变化都会导致肠道生态失调。到目前为止,人们已努力使用现代益生菌来减轻胃肠道症状。目前使用的大多数益生菌菌株属于 、 、 和 属。通过采用更新技术结合使用悉生动物模型,文化组学的最新进展为开发新型宿主特异性益生菌疗法提供了微妙的基础。在这篇综述文章中,讨论了基于微生物的疗法的最新进展,这些疗法现在可用于治疗多种疾病。然而,这些益生菌未被归类为药物,并且缺乏严格的执法来保护终端用户免受伪益生菌产品的侵害。虽然现代益生菌对未来充满希望,但需要更严格的法规来开发真正的益生菌产品,并利用最新的研究和技术对新型益生菌进行表征。本文还强调了利用基于合生元和生态益生菌最新概念开发的益生菌来减少抗生素使用的可能性。

相似文献

5
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
8
9
Gut microbiome-targeted therapies for Alzheimer's disease.针对阿尔茨海默病的肠道微生物组靶向治疗。
Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.

引用本文的文献

6
Role of Gut Microbiome in Cancer Treatment.肠道微生物群在癌症治疗中的作用。
Indian J Microbiol. 2024 Sep;64(3):1310-1325. doi: 10.1007/s12088-024-01340-4. Epub 2024 Jun 27.
7
From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?).从肝硬化到菌群失调(治愈还是并发症的循环?)
Indian J Microbiol. 2024 Sep;64(3):810-820. doi: 10.1007/s12088-024-01267-w. Epub 2024 Apr 3.

本文引用的文献

3
The urgent need for microbiology literacy in society.社会对微生物学素养的迫切需求。
Environ Microbiol. 2019 May;21(5):1513-1528. doi: 10.1111/1462-2920.14611. Epub 2019 Apr 11.
5
A next generation probiotic, .新一代益生菌,.
Crit Rev Food Sci Nutr. 2019;59(19):3227-3236. doi: 10.1080/10408398.2018.1517725. Epub 2018 Oct 29.
6
The Group: History and Health Related Applications.该小组:历史与健康相关应用。
Front Microbiol. 2018 Sep 10;9:2107. doi: 10.3389/fmicb.2018.02107. eCollection 2018.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验